Buckling of the hip joint, also referred to as “giving way,” and hip injuries may be associated with hip pain worsening in patients with symptomatic hip osteoarthritis.
Change in pain and physical function score from baseline were chosen as the co-primary endpoints.
The reliability of retrospective and daily pain measurements was comparable among patients with hip osteoarthritis, except in individuals with severe intermittent pain for whom retrospective measurements may be less reliable.
Pain catastrophizing decreases over time in patients with RA who respond to DMARD treatment.
Preliminary evidence has found an association between the cannabinoid system and other rheumatic conditions, but the studies have not provided conclusive results that could drive recommendations.
The assessment of patient-reported components of the DAS28 can be a useful way to identify patients with fibromyalgic RA.
Widespread nonarthritic pain is linked to worse patient-reported and composite psoriatic arthritis activity measures.
Factors to be considered when choosing the correct nonsteroidal anti-inflammatory drug (NSAID) for arthritis include effectiveness, concurrent health conditions, and frequency of use.
Radiofrequency denervation, typically used to treat lumbar and cervical zygapophyseal joint pain, has shown efficacy in treating thoracic zygapophyseal joint pain.
The percentage of patients with septic arthritis related to opioid or injection drug use was found to have increased from 2000 to 2013.
